With over 27 years of experience leading global clinical research across academic, government, and CRO settings, I bring a deep commitment to advancing patient care through innovation, collaboration, and operational excellence. My career spans leadership in decentralized trials, large-scale NIH-funded initiatives, and strategic CRO operations—delivering impact across oncology, pediatrics, infectious disease, neurology, and genomics.
At Duke, I led the design and launch of new research programs in epilepsy, genomics, and oncology, building the clinical trial infrastructure and operations from the ground up. She developed governance frameworks, SOPs, and monitoring models that enabled seamless study start-up and long-term scalability. Her leadership brought together investigators, institutional leaders, and operational teams to ensure regulatory readiness, data integrity, and efficient trial execution.
Key strengths include:
Leading site networks and optimizing risk-based monitoring strategies
Scaling decentralized and hybrid trials globally
Collaborating with investigators on novel protocols
Championing AI-driven, patient-focused research solutions
Managing diverse teams, vendors, and regulatory partnerships
